Advertisement Hydropothecary gets Health Canada approval to produce cannabis oil from medical marijuana - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Hydropothecary gets Health Canada approval to produce cannabis oil from medical marijuana

Hydropothecary is pleased to announce that is has been fully authorized to produce cannabis oil from medical marijuana. This represents the first such license for a company based in Quebec.

"Hydropothecary is now one of a few licensed producers able to make new, ingestible product lines. The products will be available for purchase following rigorous safety testing and authorization to sell from Health Canada. This oil licence allows the company to move ever closer to producing a true pharmaceutical," says Sebastien St-Louis, co founder and CEO.

In July, Health Canada announced it will allow licensed medical marijuana producers to produce and ship cannabis oil to patients, in addition to dried product.

"Health Canada’s decision to allow for the production and sale of oils is a major step forward. As a licensed producer, Hydropothecary can now ensure its clients have access to safe, regulated oils," says Dr. Shane Morris, Hydropothecary’s Vice President of Scientific Affairs and Stakeholder Relations.

"As with our dried product, our oils will continue to set a benchmark for quality and reliability. We are currently investigating the use of unique oil bases and will offer clients custom marijuana oils, based on their preferences."

Hydropothecary currently offers four dried Time of Day products at $15/gram — Good Morning, Midday, After Dinner, and Bedtime — all supported by the most complete and sophisticated "white glove" customer service in the industry. The oil products will mirror the Time of Day line.